Evidence supporting a late Golgi location for lactosylceramide to ganglioside GM3 conversion

Author： Allende Maria Laura Li Jianghong Darling DouglasS. Worth ChristopherA. Young Jr. WilliamW.

ISSN： 1460-2423

Source： Glycobiology, Vol.10, Iss.10, 2000-10, pp. : 1025-1032

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ganglioside GM3 inhibition of EGF receptor mediated signal transduction

By Rebbaa Abdelhadi Hurh Jay Yamamoto Hirotaka Kersey Donna S. Bremer Eric G.

Glycobiology, Vol. 6, Iss. 4, 1996-06 ,pp. : 399-406

Oxford University Press

Access to resources Recommend Favorite

Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts

By Liu Yihui Su Yan Wiznitzer Max Epifano Olga Ladisch Stephan

Glycobiology, Vol. 18, Iss. 8, 2008-08 ,pp. : 593-601

Oxford University Press

Access to resources Recommend Favorite

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy

By Labrada Mayrel Clavell Marilyn Bebelagua Yanín León Joel de Alonso Daniel F Gabri Mariano R Veloso Roberto C Vérez Vicente Fernández Luis E

Expert Opinion on Biological Therapy, Vol. 10, Iss. 2, 2010-02 ,pp. : 153-162

Informa Healthcare

Access to resources Recommend Favorite

Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppresion of activation

By Wang X-Q.

Glycobiology, Vol. 11, Iss. 7, 2001-07 ,pp. : 515-522

Oxford University Press

Access to resources Recommend Favorite

Ganglioside GM3 inhibits VEGFVEGFR-2-mediated angiogenesis: Direct interaction of GM3 with VEGFR-2

By Chung Tae-Wook Kim Seok-Jo Choi Hee-Jung Kim Keuk-Jun Kim Mi-Jin Kim Sung-Hoon Lee Hyo-Jeong Ko Jeong-Heon Lee Young-Choon Suzuki Akemi Kim Cheorl-Ho

Glycobiology, Vol. 19, Iss. 3, 2009-03 ,pp. : 229-239

Oxford University Press

Access to resources Recommend Favorite